Related Experiment Video
Updated: May 23, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Role of Cyanidin 3-glucoside Extract in the Induction of Cytotoxicity and Apoptosis in a Rat Bladder Cancer Cell Line
Haider Ammar Alubaidy1, Ali Hamid Al-Bdeery1, Esraa Abdul-Adel2
1College of Science, Al Qadisiyah University, Iraq.
Objective:
This study focused on organisms that produce natural bioactive compounds that are environmentally friendly alternatives to chemical treatments. These compounds include flavonoids derived from marine algae, including anthocyanins. Cyanidin-3-glucoside (C3G) is a natural pigment-protein complex capable of inhibiting or eradicating the proliferation of malignant cells, both in vivo and in vitro.
Methods:
This includes the AY-27 rat (BC) bladder cancer cell line. Its potential effects on inhibiting the production of isolated rat bladder tumor cells and activating cellular pathways were studied, including cytotoxicity, apoptosis, the p53 pathway, mitochondrial wall loss pathway, and partial fusion. Result: The present study documented a peak mortality rate of 84.43% in the toxicity pathway on the maximum dose of 100 µg/ml of C3G. The minimum mortality rate of 9.45% was recorded at the maximum C3G concentration of 6.25 µg/ml. In the apoptotic process, dead cells were evaluated for DNA damage. C3G promotes mitochondrial failure in AY-27 cells via the mitochondrial pathway, leading to a reduction in mitochondrial membrane potential compared to untreated AY-27 cells.
Conclusion:
The study's findings showed that C3G increased p53 gene expression in AY-27 cells during the p53 pathway. The data in the tables and figures reveal that increasing the dose or concentration of C3G over time has a lethal effect on bladder cancer cells. The results indicate that C3G promotes localized apoptosis, thereby inhibiting and slowing down the progression of bladder cancer. These findings suggest that C3G could be an active natural treatment for BC in rats, with potential for further development by international pharmaceutical companies.
